Nan Li

Founder @ Dimension

📍 San Francisco, California, United States🔄 Updated September 2026💼 18 investments📅 16 years investing🗓 Last invested Aug 2020𝕏 @upgrade_to_unlock
VC🌍 United States
18
Total investments
9
Early stage
2
Mid stage
1
Late stage
16y
Years active

Portfolio

15 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, Board Observer
Aug 2020
Swiftscale provides cell-free protein synthesis for fast expression, high-throughput synthesis, and complex protein production.
Investor, Board Observer
Jan 2020
Discovering new medicines by combining ultra throughput biochemistry and machine learning.
early stageBiotechnology
Investor
Dec 2019
n8n is a workflow automation platform that uniquely combines AI capabilities with business process automation. The platform enables connection to any app or API while maintaining the flexibility of code with the speed of no-code. Released under a fair-code license, n8n can be self-hosted and is supported by a vibrant community of developers and builders. Users can start simple and layer complexity as needed - utilizing the visual builder for quick wins, and adding custom Javascript or Python code where more control is required, enabling the connection of anything to everything. n8n is privately held, with funding from Sequoia, Felicis Ventures, Firstminute Capital, Harpoon Ventures, and others. Individual investors include Eventbrites Kevin Hartz and Supercells IIkka Paananen. n8n was founded in 2019 and is headquartered in Berlin.
Investor, Board Observer
May 2019
Octave’s mission is to create a new standard for mental health care that’s both accessible to people and sustainable for providers. By broadening pathways for care delivery, we can better serve our community and meet the growing need for mental health care. We partner with clients to develop personalized care plans to best suit the individual's needs. Grounded in science, Octave enables clients to experience profound change that is just as measurable as it is meaningful. We are growing quickly and seeking colleagues who are passionate about high-quality mental healthcare and ready to join our movement to make it more accessible. Learn more at https://findoctave.com/careers-overview
Investor
Nov 2018
Building high-performance genetic technologies that transform patient lives.
Investor, Board Observer
Oct 2016
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Investor
2015
Tempo Automation is transforming the way companies innovate and bring new electronic products to market. Our breakthrough, software-automated PCBA manufacturing platform delivers unprecedented speed, quality and transparency at the most critical time in a product’s lifecycle – prototype through new product introduction – when fast iteration and time to market are imperatives. Customers who count on Tempo Automation for this strategic advantage include the leading innovators in aerospace, medical technology, semiconductor, industrial technology, automotive and other key industries.
Investor
2014
Human API Inc. is now proud to be part of LexisNexis® Risk Solutions. We have combined our consumer-driven health data network with advanced analytics from LexisNexis Risk Solutions to offer a next-generation consumer consent management solution that will enable more efficient life insurance underwriting and improve care coordination within the healthcare ecosystem. Learn more about us here: https://risk.lexisnexis.com/products/health-intelligence-ehr https://risk.lexisnexis.com/products/humanapi
Investor, Board Observer
2013
We’re Blue River, a team of innovators driven to radically change agriculture by creating intelligent machinery. We empower our customers – farmers - to implement more sustainable solutions: optimize chemical usage, reimagining routine processes, and improving farming yields year after year. We believe that focusing on the small stuff – pixel-by-pixel and plant-by-plant - leads to big gains. By partnering with John Deere, we are innovating computer vision, machine learning, robotics and product management to solve monumental challenges for our customers. Our people are at the heart of what we do. Through cross-discipline collaboration, this mission-driven and daring team is eager to define the new frontier of agricultural robotics. We are always asking hard questions, rapidly iterating, and getting our boots in the field to figure it out. We won’t give up until we’ve made a tangible and positive impact on agriculture.
Investor, Board Observer, Advisor
2013
Zymergen is now a part of Ginkgo Bioworks!
Investor
2013
Planet is the leading provider of global, daily satellite imagery and insights. Planet is driven by a mission to image all of Earth’s landmass every day, and make global change visible, accessible, and actionable. Founded in 2010 by three NASA scientists, Planet designs, builds, and operates the largest fleet of imaging satellites, as well as online software, tools and analytics needed to deliver data to users. Decision makers in business, government, and within organizations use Planets data and machine learning-powered analytics to develop new technologies, drive revenue, power research, and make informed, timely decisions to solve our worlds toughest challenges. Visit us at https://www.planet.com/
Investor
2013
Formlabs builds the tools that make it possible for anyone to bring their ideas to life. Headquartered in Somerville, Massachusetts with offices in Germany, Japan, China, Singapore, and Hungary, Formlabs is the professional 3D printer of choice for engineers, designers, manufacturers, healthcare providers, and decision makers around the globe. Formlabs products include the Form Series SLA printers, Fuse Series SLS printers, Form Wash and Form Cure post-processing solutions.
Investor, Board Observer
2011
4moms has transformed the baby gear industry by leveraging technology and functional design to create dramatically better products, like the 4moms mamaRoo® infant seat that replicates the bouncing and swaying motions parents make when soothing their babies; the 4moms breeze® playard that opens or closes in one simple step; and the 4moms high chair, which uses magnetic technology to make mealtime easier. The company, founded in 2005 and based in Pittsburgh, Penn., currently sells its products at buy buy BABY, Amazon, Best Buy, Target, walmart.com, select specialty retailers, and at 4moms.com. If youre interested in learning more, take a look at our openings at http://www.4moms.com/careers and see if theres a perfect fit for you at 4moms. We look forward to hearing from you!
late stageManufacturing
Venture Capital Investor
Sep 2010
BCV helps founders build iconic businesses that transform the way we live and work. We invest in B2B software startups from seed to growth across our four domains of Fintech, Commerce, Apps, and Infra. For over 20 years and with over $10B under management, BCV has helped launch and commercialize more than 400 companies, including Attentive, Bloomreach, Clari, Docusign, Flywire, LinkedIn, Moveworks, Rapid7, and Redis. BCV has offices in San Francisco, Palo Alto, New York, and Boston, and you can follow us on Twitter @BainCapVC.
Venture Capital Investor
2010
BCV helps founders build iconic businesses that transform the way we live and work. We invest in B2B software startups from seed to growth across our four domains of Fintech, Commerce, Apps, and Infra. For over 20 years and with over $10B under management, BCV has helped launch and commercialize more than 400 companies, including Attentive, Bloomreach, Clari, Docusign, Flywire, LinkedIn, Moveworks, Rapid7, and Redis. BCV has offices in San Francisco, Palo Alto, New York, and Boston, and you can follow us on Twitter @BainCapVC.
Experience · 22 entries
All (22)
Investments (18)
Founder (1)
Board (7)
2022
Founder & Managing Partner
Jul 2022
A first-of-its-kind fund partnering with founders at the interface of technology and life sciences to transform the trajectory of life on earth
2020
Investor, Board Observer
Aug 2020
Swiftscale provides cell-free protein synthesis for fast expression, high-throughput synthesis, and complex protein production.
Investor, Board Observer
Jan 2020
Discovering new medicines by combining ultra throughput biochemistry and machine learning.
early stageBiotechnology
2019
Investor
Dec 2019
n8n is a workflow automation platform that uniquely combines AI capabilities with business process automation. The platform enables connection to any app or API while maintaining the flexibility of code with the speed of no-code. Released under a fair-code license, n8n can be self-hosted and is supported by a vibrant community of developers and builders. Users can start simple and layer complexity as needed - utilizing the visual builder for quick wins, and adding custom Javascript or Python code where more control is required, enabling the connection of anything to everything. n8n is privately held, with funding from Sequoia, Felicis Ventures, Firstminute Capital, Harpoon Ventures, and others. Individual investors include Eventbrites Kevin Hartz and Supercells IIkka Paananen. n8n was founded in 2019 and is headquartered in Berlin.
Investor, Board Observer
May 2019
Octave’s mission is to create a new standard for mental health care that’s both accessible to people and sustainable for providers. By broadening pathways for care delivery, we can better serve our community and meet the growing need for mental health care. We partner with clients to develop personalized care plans to best suit the individual's needs. Grounded in science, Octave enables clients to experience profound change that is just as measurable as it is meaningful. We are growing quickly and seeking colleagues who are passionate about high-quality mental healthcare and ready to join our movement to make it more accessible. Learn more at https://findoctave.com/careers-overview
Show all 22 entries ↓
Investment activity
2010–2020 · 18 investments
201032011220135201412015120161201812019220202
Recent (last 2 years)Earlier